全文获取类型
收费全文 | 4578篇 |
免费 | 175篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 165篇 |
妇产科学 | 71篇 |
基础医学 | 541篇 |
口腔科学 | 143篇 |
临床医学 | 572篇 |
内科学 | 705篇 |
皮肤病学 | 23篇 |
神经病学 | 498篇 |
特种医学 | 129篇 |
外科学 | 579篇 |
综合类 | 25篇 |
一般理论 | 1篇 |
预防医学 | 427篇 |
眼科学 | 15篇 |
药学 | 350篇 |
肿瘤学 | 468篇 |
出版年
2021年 | 30篇 |
2020年 | 35篇 |
2019年 | 45篇 |
2018年 | 60篇 |
2017年 | 46篇 |
2016年 | 51篇 |
2015年 | 61篇 |
2014年 | 90篇 |
2013年 | 174篇 |
2012年 | 237篇 |
2011年 | 221篇 |
2010年 | 151篇 |
2009年 | 126篇 |
2008年 | 287篇 |
2007年 | 300篇 |
2006年 | 291篇 |
2005年 | 326篇 |
2004年 | 283篇 |
2003年 | 293篇 |
2002年 | 265篇 |
2001年 | 67篇 |
2000年 | 34篇 |
1999年 | 50篇 |
1998年 | 72篇 |
1997年 | 78篇 |
1996年 | 67篇 |
1995年 | 53篇 |
1994年 | 50篇 |
1993年 | 40篇 |
1992年 | 42篇 |
1991年 | 50篇 |
1990年 | 28篇 |
1989年 | 31篇 |
1988年 | 38篇 |
1987年 | 35篇 |
1986年 | 38篇 |
1985年 | 39篇 |
1984年 | 41篇 |
1983年 | 48篇 |
1982年 | 50篇 |
1981年 | 42篇 |
1980年 | 36篇 |
1979年 | 30篇 |
1978年 | 30篇 |
1977年 | 32篇 |
1976年 | 22篇 |
1975年 | 29篇 |
1974年 | 21篇 |
1968年 | 23篇 |
1967年 | 24篇 |
排序方式: 共有4765条查询结果,搜索用时 15 毫秒
81.
Halfdan S?rbye Bengt Glimelius Ake Berglund Tone Fokstuen Kjell Magne Tveit Morten Braendengen Dagfinn ?greid Olav Dahl 《Journal of clinical oncology》2004,22(1):31-38
PURPOSE: This Nordic multicenter phase II study evaluated the efficacy and safety of oxaliplatin combined with the Nordic bolus schedule of fluorouracil (FU) and folinic acid (FA) as first-line treatment in metastatic colorectal cancer. PATIENTS AND METHODS: Eighty-five patients were treated with oxaliplatin 85 mg/m(2) as a 2-hour infusion on day 1, followed by a 3-minute bolus injection with FU 500 mg/m(2) and, 30 minutes later, by a bolus injection with FA 60 mg/m(2) every second week. The same doses of FU and FA were also given on day 2. RESULTS: Fifty-one of 82 assessable patients achieved a complete (n = 4) or partial (n = 47) response, leading to a response rate of 62% (95% CI, 52% to 72%). Nineteen patients showed stable disease, and 12 patients had progressive disease. Thirty-eight of the 51 responses were radiologically confirmed 8 weeks later (confirmed response rate, 46%; 95% CI, 36% to 58%). The estimated median time to progression was 7.0 months (95% CI, 6.3 to 7.7 months), and the median overall survival was 16.1 months (95% CI, 12.7 to 19.6 months) in the intent-to-treat population. Neutropenia was the main adverse event, with grade 3 to 4 toxicity in 58% of patients. Febrile neutropenia developed in seven patients. Nonhematologic toxicity consisted mainly of neuropathy (grade 3 in 11 patients and grade 2 in another 27 patients). CONCLUSION: Oxaliplatin combined with the bolus Nordic schedule of FU+FA (Nordic FLOX) is a well-tolerated, effective, and feasible bolus schedule as first-line treatment of metastatic colorectal cancer that yields comparable results compared with more complex schedules. 相似文献
82.
A Systematic Overview of Radiation Therapy Effects in Cervical Cancer (Cervix Uteri) 总被引:2,自引:0,他引:2
Nina Einhorn Claes Trop Mona Ridderheim Karin Boman Bengt Sorbe Eva Cavallin-st hl 《Acta oncologica (Stockholm, Sweden)》2003,42(5):546-556
A systematic review of radiation therapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The procedures for evaluation of the scientific literature are described separately (Acta Oncol 2003; 42: 357-365). This synthesis of the literature on radiation therapy for cervical cancer is based on data from 1 meta-analysis and 34 randomized trials. In total, 35 scientific articles are included, involving 7 952 patients. The results were compared with those of a similar overview from 1996 including 34 024 patients. The conclusions reached can be summarized in these points: There are limited scientific data supporting that postoperative pelvic radiotherapy improves disease-free survival in early cervical cancer. No firm conclusion can be drawn.There is moderate scientific evidence that external beam radiotherapy combined with brachytherapy gives a similar disease-free and overall survival rate as radical hysterectomy in early cervical cancer.There is strong scientific evidence that concomitant radiochemotherapy improves disease-free and overall survival compared to radiotherapy alone in early cervical cancer.The NCI has recently published an announcement stating that cisplantin-based chemotherapy should be used concomitantly with radiotherapy in cervical cancer. No solid documentation for this statement can be found concerning locally advanced stages (>IIB).There is a strong scientific evidence that cisplatin-based chemotherapy given concomitantly with radiotherapy is superior to concomitant chemotherapy with hydroxyurea.There is no scientific evidence to show that neoadjuvant chemotherapy followed by radiotherapy improves disease-free or overall survival compared to radiotherapy alone in patients with localized cervical cancer.There is moderate scientific evidence that high-dose-rate brachytherapy gives the same local control rate as low-dose-rate brachytherapy but with fewer rectal complications. 相似文献
83.
Ulrik Ringborg David Bergqvist Bengt Brorsson Eva Cavallin-st hl Jeanette Ceberg Nina Einhorn Jan-erik Fr din Johannes J rhult Gunilla Lamnevik Christer Lindholm Bo Littbrand Anders Norlund Urban Nyl n M ns Ros n Hans Svensson Torgil R. M ller 《Acta oncologica (Stockholm, Sweden)》2003,42(5):357-365
A systematic assessment of radiotherapy for cancer was conducted by The Swedish Council on Technology Assessment in Health Care (SBU) and published in 1996. The assessment reviewed the scientific literature up to 1993 on the use of radiotherapy in the treatment of solid tumours, and estimated the costs associated with radiotherapy. It also described the current practise of radiotherapy in Sweden 1992 and compared practise with scientific knowledge. The SBU has now conducted a follow-up study on radiotherapy for cancer, including a review of the scientific literature from 1994 and a prospective survey of radiotherapy practise in Sweden 2001. The following conclusions were drawn: The role of radiotherapy as an important form of treatment for cancer with both curative and palliative intent has been further confirmed.The use of radiotherapy in Sweden has increased and is now at the internationally recommended level.Radiotherapy in Sweden is mostly given in accordance with the scientific evidence but may still be underutilized in certain situations.The resources for radiotherapy are being utilized more efficiently.The costs of radiotherapy are still 5% of the total cost of cancer care, while the cost of an individual treatment (fraction) has decreased.The need for radiotherapy capacity will increase. In addition, half of the treatment equipment will have to be replaced in the next few years. 相似文献
84.
[18F] FDG PET in Gastric Non-Hodgkin's Lymphoma 总被引:1,自引:0,他引:1
Miriam Rodriguez H kan Ahlstr m Anders Sundí n Suzanne Rehn Christer Sundstr m Hans Hagberg Bengt Glimelius 《Acta oncologica (Stockholm, Sweden)》1997,36(6):577-584
The possibility of using [18F] FDG PET for assessment of tumor extension in primary gastric non-Hodgkin's lymphoma (NHL) was studied in 8 patients (6 high-grade and 2 Iow-grade, one of the MALT type) and in a control group of 7 patients (5 patients with NHL without clinical signs of gastric involvement, 1 patient with NHL and benign gastric ulcer and 1 patient with adenocarcinoma of the stomach). All patients with gastric NHL and the two with benign gastric ulcer and adenocarcinoma, respectively, underwent endoscopy including multiple biopsies for histopathological diagnosis. All patients with high-grade and one of the two with low-grade NHL and the patient with adenocarcinoma displayed high gastric uptake of [18F] FDG corresponding to the pathological findings at endoscopy and/or CT. No pathological tracer uptake was seen in the patient with low-grade gastric NHL of the MALT type. In 6/8 patients with gastric NHL, [18F] FDG PET demonstrated larger tumor extension in the stomach than was found at endoscopy, and there was high tracer uptake in the stomach in two patients who were evaluated as normal on CT. [18F] FDG PET correctly excluded gastric NHL in the patient with a benign gastric ulcer and in the patients with NHL without clinical signs of gastric involvement. Although the experience is as yet limited, [18F] FDG PET affords a novel possibility for evaluation of gastric NHL and would seem valuable as a complement to endoscopy and CT in selected patients, where the technique can yield additional information decisive for the choice of therapy. 相似文献
85.
Ulrik N Lassen Fred R Hirsch Kell Østerlind Bengt Bergman Per Dombernowsky 《Lung cancer (Amsterdam, Netherlands)》1998,20(3):151-160
During the past two decades many different treatment regimens of combination chemotherapy have been applied in extensive stage small-cell lung cancer (SCLC). This study was carried out to identify whether these modifications have resulted in an improved overall survival for extensive stage during the past two decades. In total, 1111 patients with extensive stage SCLC were included in six consecutive randomised trials in our setting from 1973 until 1992. Of these, 526 patients treated in the early period (1973–1981) were compared with 585 patients treated in the late period (1981–1992) with respect to pretreatment prognostic factors, staging, treatment and outcome. No change in the distribution of prognostic factors was detected and the frequency of patients with extensive stage was equal in the two periods, and no difference in overall response rates and survival was observed (P=0.49). Median survival in the two periods was 208 days and 215 days, respectively. No stage migration or treatment-related improved outcome was observed in extensive disease. We suggest restricting aggressive treatment to patients with favorable prognosis and long-term survival as a realistic aim. 相似文献
86.
87.
Claudia Sch?llkopf Karin Ekstr?m Smedby Henrik Hjalgrim Klaus Rostgaard Ole Gadeberg G?ran Roos Anna Porwit-Macdonald Bengt Glimelius Hans-Olov Adami Mads Melbye 《Cancer epidemiology, biomarkers & prevention》2005,14(7):1791-1796
BACKGROUND: Epidemiologic evidence of an association between tobacco smoking and non-Hodgkin's lymphoma has been conflicting. This may reflect that non-Hodgkin's lymphoma comprises several distinct disease entities with different etiologies, as some studies have indicated an association between smoking and follicular lymphoma. OBJECTIVE: To investigate the association between cigarette smoking and non-Hodgkin's lymphoma risk, overall and by subtype. METHODS: As part of a nationwide Danish-Swedish population-based case-control study, we interviewed 3,055 incident non-Hodgkin's lymphoma patients and 3,187 population controls. All lymphomas were uniformly classified according to the WHO classification. We used unconditional logistic regression to estimate adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for the association between cigarette smoking and risk of non-Hodgkin's lymphoma. RESULTS: Cigarette smoking was not associated with the risk of non-Hodgkin's lymphoma overall (OR, 0.97; 95% CI, 0.87-1.08) nor with the major subgroups such as diffuse large B-cell lymphoma (OR, 0.94; 95% CI, 0.79-1.10), chronic lymphocytic leukemia (OR, 0.86; 95% CI, 0.72-1.02), or follicular lymphoma (OR, 1.03; 95% CI, 0.85-1.24). Female smokers were at a marginally increased risk of follicular lymphoma (OR, 1.41; 95% CI, 1.04-1.92). Men who had ever smoked had a significantly increased risk of T-cell lymphoma (OR, 1.67; 95% CI, 1.11-2.51). No dose-response association with cigarette smoking could be established for any lymphoma subgroup. CONCLUSION: We found little evidence of an association between cigarette smoking and non-Hodgkin's lymphoma risk overall. Although increased risks of follicular lymphoma in female smokers and of T-cell lymphoma in male smokers were suggested, no dose-response relationship was observed, leaving limited support for causality. 相似文献
88.
89.
90.
Idor Svensson Linda Fälth Bengt Persson Staffan Nilsson 《Psychiatry, Psychology and Law》2017,24(3):440-457
The aim of the present study was to investigate the effect of a short period, 15 sessions, of reading interventions in a sample of adult forensic psychiatric patients: 61 patients with decoding difficulties – 44 in the experimental group and 17 in the comparison group – with an average age of 31.6 participated. Of these, 36% were female, and 29% had an immigrant background. The participants carried out a battery of reading tests. The results in the experimental group showed a medium effect size (d = .36 to .76) on all reading tests between pre- and post-test. The comparison group, however, showed no gain at all between the test occasions. The results indicate that a proportionally low reading intervention effort produces improvement in reading. This study discusses the importance of including reading assessment and offering remediation in order to reach optimal future social adjustment for patients in forensic clinics. 相似文献